Source:Scientia GlobalOctober 17, 2020
Their vision is to develop therapeutics that can slow the progression of the disease, and ultimately, treat and even prevent it.
Source:Journal of Clinical PathwaysOctober 8, 2020
Expanded genomic panel testing was clinically impactful in most patients with high-risk cancer, yet payers reimbursed only 10.75% of the charge on average, if reimbursed at all, new study found.
- September 29, 2020
Dr. Bhagat received this recognition for being in the top 1% of scholars writing about Peripheral T-Cell Lymphoma over the past 10 years.
There are currently no upcoming events.